HSC01
clear graphic
clear graphic

Study to compare Botox and Dysport for forehead wrinkles

Posted: Tuesday, October 05, 2010 · Volume: XLIII · Issue: 20

Share |

Media contact: Elizabeth Allen, 210-450-2020

Bahar F. Firoz, M.D., M.P.H., is one of two principal investigators on the Botox and Dysport study. Dr. Firoz is an associate professor and director of Mohs surgery in the Division of Dermatology and Cutaneous Surgery.
clear graphic
Bahar F. Firoz, M.D., M.P.H., is one of two principal investigators on the Botox and Dysport study. Dr. Firoz is an associate professor and director of Mohs surgery in the Division of Dermatology and Cutaneous Surgery.clear graphic

Email Printer Friendly Format
 

SAN ANTONIO (Sept. 29, 2010) — The brand Botox has been around a while, but it’s getting a fresh test in a new study at The University of Texas Health Science Center at San Antonio comparing Botox with another wrinkle treatment.

The School of Medicine’s Division of Dermatology and Cutaneous Surgery is conducting an Institutional Review Board-approved clinical study comparing Botox with Dysport, another FDA-approved drug used in standard doses for the treatment of forehead wrinkles. In this study, volunteers will receive injections of Botox Cosmetic and Dysport into the forehead to reduce wrinkles. It will compare Botox to Dysport, with one injected on each side of the area between the eyebrows.

Participants will receive the injection in February at the Cancer Therapy & Research Center at the UT Health Science Center San Antonio. The dermatology clinic is on the third floor of the Grossman building. The dermatology physicians are part of the School of Medicine’s multispecialty practice called UT Medicine San Antonio.

Patients will also have four scheduled follow-up visits during the six months after injection. The follow-up visits will be for photographs only, except for patients who need a touch-up in the first week. There is some cost to the patient, although injections will be offered at a reduced cost of about $200. The typical cost is approximately $700.

Principal investigators on the study are Bahar F. Firoz, M.D., M.P.H., and Wenhong Zhou, M.D. Although the study is already full, those who qualified will be scheduled for an injection in February. Dr. Firoz is an associate professor and director of Mohs surgery in the Division of Dermatology and Cutaneous Surgery. Dr. Zhou is a resident in the Division of Dermatology.

The study cannot accept participants who are pregnant, breastfeeding or planning pregnancy, anyone planning to receive Botox or Dysport injections from an outside physician within the next six months, or anyone with an allergy to the medications. Other possible conditions that would disqualify a participant will be discussed at the informational appointment.

NOTE: This study is no longer accepting participants.

# # #

UT Medicine San Antonio is the clinical practice of the School of Medicine at the UT Health Science Center San Antonio. With more than 700 doctors — all faculty from the School of Medicine — UT Medicine is the largest medical practice in Central and South Texas, with expertise in more than 60 different branches of medicine. Primary care doctors and specialists see patients in private practice at UT Medicine’s clinical home, the Medical Arts & Research Center (MARC), located in the South Texas Medical Center at 8300 Floyd Curl Drive, San Antonio 78229. Most major health plans are accepted, and there are clinics and physicians at several local and regional hospitals, including CHRISTUS Santa Rosa, University Hospital and Baptist Medical Center. Call 210-450-9000 to schedule an appointment, or visit www.UTMedicine.org for a complete listing of clinics and phone numbers.

 
bottom bar

»printer friendly format...
»view more articles by issue#...
»search articles by keywords...
Arrow - to top
HSC Alert - Sign up today
Calendar of Events
Tell Us Your Story Idea
Submission Guidelines
Arrow - to top